Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma
NCT01965834
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class
Stopped
Lack of adequate accrual.
Conditions
Multiple Myeloma
Interventions
DRUG:
Fenofibrate
Sponsor
University of Miami